Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Oscillate

Data updated

London, United Kingdom

Oscillate PLC is a publicly listed investment company on the Aquis Stock Exchange Growth Market. Its public corporate filings show it is incorporated in England and Wales, with a registered office in London, United Kingdom.

Oscillate became relevant to the psychedelic ecosystem after broadening its investment strategy in 2021 to cover medical psychedelics. Public company materials indicate it has held an investment portfolio that included psychedelic-sector opportunities and that the company has been focused on early-stage companies in the space.

Investor Context

Venture Capital

Investment Context

This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.

Oscillate PLC has described itself as an investment company and, in shareholder materials, said it broadened its strategy in April 2021 to cover medical psychedelics. Public disclosures also describe a portfolio weighted toward early-stage companies and note that the company has made investments in the medical psychedelic industry, making it a public-market capital source with relevance to psychedelic drug development and adjacent healthcare opportunities.

Investor Type

Venture Capital Fund

Geographic Scope

Global

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement

Active

Investment Stage Focus

SeedSeries A/BGrowth / Late Stage

Investment Focus Areas

Drug Development

Investment Orientation

Engagement Status

Active

Investor Type

Venture Capital Fund

Investment Website

Quick Facts

Founded
2006
HQ
London, United Kingdom
Website
Visit